In a study involving more than 11,000 men enrolled in the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial, about one quarter of elevated prostate-specific antigen (PSA) results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback